Steik Jason Paul
Known title: Chief Clinical OfficerCIK: 0002078374
Associated companies
Transaction History
| PNTG | ▼ Sell | Open Market | 1,394 | $54K | 8/6/2026 | View on chart |
| PNTG | ▼ Sell | Open Market | 1,394 | $54K | 8/6/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Pennant Group Featured in Cash-Flow Stock List
The Pennant Group was included in a recent Yahoo Finance article titled '3 Cash-Producing Stocks We Steer Clear Of.' This inclusion highlights the company's cash flow characteristics as a point of discussion among investors. The stock currently trades within its 52-week range, with an average analyst target price of $46.83.
Pennant Group Featured in Cash-Flow Stock List. The Pennant Group was included in a recent Yahoo Finance article titled '3 Cash-Producing Stocks We Steer Clear Of.' This inclusion highlights the company's cash flow characteristics as a point of discussion among investors. The stock currently trades within its 52-week range, with an average analyst target price of $46.83.